Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C07AB04	ACEBUTOLOL BIOGARAN	G	Acebutolol HCl - 400mg	400mg	Tablet, coated	615,480 L.L
C07AB04	ACEBUTOLOL BIOGARAN	G	Acebutolol HCl - 200mg	200mg	Tablet, coated	464,970 L.L
C09DA03	ARBITEN PLUS	G	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg		Tablet	544,256 L.L
C07AB07	APO-BISOPROLOL	G	Bisoprolol fumarate - 5mg	5mg	Tablet	923,220 L.L
C09DA03	ARBITEN PLUS	G	Valsartan - 160mg, Hydrochlorothiazide - 25mg		Tablet	579,196 L.L
L04AA32	APRIVA STARTER PACK	G	Apremilast - 10mg, Apremilast - 20mg, Apremilast - 30mg		Tablet, film coated	22,154,866 L.L
D11AX01	ALOPEXY	G	Minoxidil - 20mg/ml	2%	Solution	532,162 L.L
D11AX01	ALOPEXY	G	Minoxidil - 2%	2%	Solution	532,162 L.L
L04AA32	APRIVA	G	Apremilast - 30mg	30mg	Tablet, film coated	41,455,526 L.L
D11AX01	ALOPEXY	G	Minoxidil - 50mg/ml	5%	Solution	896,343 L.L
D11AX01	ALOPEXY	G	Minoxidil - 5%	5%	Solution	896,343 L.L
C09DA04	ANDARAN PLUS	G	Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	598,051 L.L
M01AH05	ARTRIX 60	G	Etoricoxib - 60mg	60mg	Tablet, film coated	1,054,596 L.L
J01DD04	AXONE	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution	4,047,654 L.L
J01DD04	AXONE 1G IM	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution+diluent	438,093 L.L
R03AK13	AEROCORT-A HFA	G	Salbutamol - 100mcg/dose, Beclometasone - 50mcg/dose		Metered dose inhaler	541,569 L.L
S01AA26	AZYTER	G	Azithromycin (dihydrate) - 15mg/g	15mg/g	Drops solution	412,560 L.L
N02BE01	ADOL	G	Paracetamol - 250mg	250mg	Suppository	124,977 L.L
N02BE01	ALGIVIC	G	Paracetamol - 250mg	250mg	Suppository	215,015 L.L
D11AX11	AVOQUIN	G	Hydroquinone - 4%	4%	Cream	916,501 L.L
M01AH05	ARTRIX 90	G	Etoricoxib - 90mg	90mg	Tablet, film coated	1,228,656 L.L
C09DA04	ANDARAN PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	598,051 L.L
D11AX18	ALMIRAL	G	Diclofenac sodium - 1% w/w	1% w/w	Gel	396,434 L.L
N02BE01	ADOL	G	Paracetamol - 500mg	500mg	Suppository	131,697 L.L
N02BE01	ALGIVIC	G	Paracetamol - 500mg	500mg	Suppository	147,183 L.L
N02BE01	ADOL	G	Paracetamol - 125mg	125mg	Suppository	107,507 L.L
N02BE01	ALGIVIC INFANT	G	Paracetamol - 125mg	125mg	Suppository	199,657 L.L
S01AE07	AROX	G	Moxifloxacin (HCl) - 0.5%	0.5%	Drops	423,310 L.L
C09DA04	ANDARAN PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 25mg		Tablet, film coated	940,435 L.L
R03BA02	AERONIDE	G	Budesonide - 200mcg	200mcg	Capsule, inhalation	1,150,329 L.L

...